FDA Bans Juul E-cigarettes Sales in US, Experts React

Jul.26.2022
FDA Bans Juul E-cigarettes Sales in US, Experts React
US FDA bans Juul e-cigarettes due to concerns about their marketing towards youth. No evidence they help tobacco consumption.

A report by Medscape reveals that the United States Food and Drug Administration (FDA) has banned the sale of Juul brand e-cigarettes in the country. Dr. Pierre Bizel, a member of Belgium's national anti-tobacco alliance, believes that the primary intention of these products is to attract more smokers and there is no scientific evidence to suggest that e-cigarettes help eliminate tobacco consumption.


The FDA has announced that Juul Labs and their USB-shaped e-cigarettes and flavored nicotine pods have failed to demonstrate that their marketing is "appropriate for the protection of public health." The San Francisco-based startup has been accused of playing a significant role in the surge of youth e-cigarette use, particularly through advertising and marketing aimed at high school students, in an effort to justify its decision.


In 2021, Juul Labs paid $51,000 to fully fund the May-June issue of the American Journal of Health Behavior, which published 11 studies sponsored by Juul that aimed to demonstrate how their products help smokers quit smoking. While all articles underwent peer review (with the twelfth article being rejected), there are questions about the legitimacy of the process from the academic community. The version of the journal has been described by the American Prospect as "taking academic corruption to a new level.


A study that appeared in Tobacco Control in 2021 indicated that less than half of the scientific conclusions in clinical trials sponsored by Juul Labs were accurate. In response to regulatory pressure, the company suspended the sale of flavored pods popular among young people in 2019 and agreed to review its marketing strategies.


MediQuality interviewed Bizel, who is also the Director of Lifestyle Habits Research at the Belgian Health Observatory in Halle.


Is Juul electronic cigarette widely considered a trojan horse that attracts young smokers, according to MediQuality today?


Bizel stated that Juul products were withdrawn from the Belgian market in 2019, but it is clear that they appeal to young people. Resembling a USB stick, the product can be charged on a laptop and comes with separate pods offering different flavors. The product is clearly designed to attract teenagers and young adults, and is not targeted towards responsible adult smokers seeking a way to quit smoking. Such e-cigarettes can only create addiction and then increase the number of smokers. Like other products currently available, such as Puff Bar, the aim remains the same: these fluorescent or candy pink disposable e-cigarettes produce little smoke, are highly discreet, have a very high nicotine content, and attract consumers. After all, these are products manufactured by nicotine sellers.


The Belgian Alliance for Smoke-Free Society believes that e-cigarettes need to attract new customers. However, according to a recent statement by the Belgian Superior Health Council, these products are "not harmless". As such, they pose a risk to young people who need to be protected from their harmful effects.


The device can certainly play a role in smoking cessation, but only in specific circumstances, much like any medication used to aid in treatment. Otherwise, its effectiveness will be very low. Without consultation, doctors, or behavioral support, relapse is almost certain. The device can only be used in a therapeutic environment, much like many other tools. Unfortunately, no e-cigarette manufacturer - Juul or any other company - has applied for marketing authorization for such products to eliminate tobacco consumption. As a result, drug agencies from different countries are unable to assess their positive effects on eliminating tobacco consumption and approve them.


Regardless of what type of cigarette-like aerosol may be presented, no manufacturer can claim that these devices are aids to quitting smoking. Manufacturers are promoting these devices as another way to smoke or as a replacement, but they are not official tools for smoking cessation. While scholars and researchers are attempting to determine the potential benefits of such products, it has not been officially declared as an auxiliary tool to counter tobacco consumption. There is ambiguity involved.


Is the only acceptable electronic cigarette device one that is proven effective and sold in pharmacies, according to MediQuality?


Bizel stated that the manufacturer's strategy does not focus on establishing a presence in the medical field nor gaining the support of tobacco addiction experts or smoking cessation hotlines. Instead, their goal is to create a consumer product that generates as many nicotine-dependent smokers as possible. They have no interest in developing a presence in the treatment industry. Therefore, it is essential to note that the only guarantee of efficacy is through supervision and gradual dose reduction.


This is a market seeking long-term dependence, as there are currently no time restrictions for users of this product. It is important to note, as shown by the national health survey conducted by Belgium's public health research institute, Sciensano, and a survey by the Belgian Cancer Foundation, that 70% of e-cigarette users also smoke traditional cigarettes, making them dual users. This raises questions about the effectiveness of e-cigarettes as a smoking cessation tool, as if they were effective, users would quit smoking altogether. In fact, e-cigarettes increase the overall intake of nicotine, which in turn increases the number of products in circulation and manufacturers' profits. When looking at the big picture, both in Belgium and globally, e-cigarettes have not made any changes to cigarette sales. The same amount of traditional tobacco is still being sold. This new product allows manufacturers to profit from both sides.


Will Juul electronic cigarettes disappear forever, according to MediQuality?


Bizel expressed surprise at the possibility of Juul e-cigarettes returning to the market, but notes that other e-cigarettes are still widely available. A notable recent development in the US is the reduction of nicotine levels in cigarettes by approximately 90%. While this is a significant step towards normalizing cigarette use, it must be properly validated, particularly considering the variety of nicotine types such as salt nicotine and freebase nicotine. This initiative is part of a broader ambitious public health plan to reduce cancer deaths, with President Joe Biden committing to a 50% reduction in cancer deaths within 25 years. However, the five major tobacco companies will need to react, meaning change will not happen overnight.


I am sorry, but as an AI language model, I am already programmed to generate news articles in standard journalistic English. Can you please provide me with a text that needs to be translated?



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How Investors Are Repricing the Global Tobacco Industry as Nicotine Markets Shift
How are investors reassessing the global tobacco industry as nicotine markets evolve? In an interview with 2Firsts, Charlie Chen, Head of Research at CCB International Securities, forecasts annual growth of 30–50% for nicotine pouches, outpacing vaping and heated tobacco. He examines how regulatory enforcement, shifting market shares and new business models are influencing company valuations. The report also explores differences between multinational tobacco groups and Chinese companies, drawing on insights from the New Approaches Summit on profitability, investment strategies and industry consolidation.
Nov.11
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
Japan's Heated Tobacco Use Rises From 0.1% to 14.9% Over a Decade as Growth Extends Beyond Cigarette Switching
A decade-long study published in The Lancet Regional Health – Western Pacific found that heated tobacco product use in Japan increased from 0.1% in 2015 to 14.9% in 2025, although growth slowed after 2018. Switching from conventional cigarettes remained an important source of HTP uptake, while the contribution from previously non-current users increased. Approximately 56% of HTP users also smoked conventional cigarettes in 2025. Separate industry data show that Japan's heated tobacco sales reached 73.4 billion units in fiscal 2025, approaching conventional cigarette sales of 78.2 billion units.
SCIENCE
Nov.10
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands (TPB) reported third-quarter 2026 Modern Oral net sales of $74.4 million on November 9, up 102.9% year over year and representing 49.2% of consolidated net sales. Total company net sales rose 27.0% to $151.1 million, while net income attributable to TPB declined 81.4% to $3.93 million. The company is expanding the US retail presence of its FRE and ALP nicotine pouch brands and expects its Modern Oral chain-store footprint to grow by more than 70% during 2026. Selling, general and administrative expenses increased 69.1% to $75.3 million, while PMTA-related expenses reached approximately $3.15 million and manufacturing start-up costs totaled about $593,000. ALP plans to open a branded pop-up in New York City's SoHo neighborhood on November 13, alongside a marketing campaign extending into January 2027. TPB owns 50% of ALP but consolidates the venture in its financial statements.
company
Nov.11